Revenue
attach_money958M USD
YoY +432.1%
MDGLMadrigal Pharmaceuticals, Inc.$ --
Madrigal Pharmaceuticals, Inc.
MDGL
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-300M USD
YoY +39.7%
Net Income
verified-288M USD
YoY +38.1%
EPS
pie_chart-12.85USD
YoY +41.3%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress76.9%On Track
Revenue Progress311.3M
Revenue Forecast1.5B
Net Income Progress-94.4M
Net Income Forecast-122.7M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.